Saturn V Capital Management LP Diversified Active

CIK: 0001964437 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Nov 14, 2023

Total Value ($000): $238,925 (100.0% shares, 0.0% debt)

Holdings (20)

CRNX CRINETICS PHARMACEUTICALS IN 14.0%
Value ($000) $33,504 Shares 1,126,579 Est. Cost $18.62 Unrealized +10.7%
KALV KALVISTA PHARMACEUTICALS INC 7.3%
Value ($000) $17,433 Shares 1,810,246 Est. Cost $7.51 Unrealized +36.0%
COGT COGENT BIOSCIENCES INC 7.2%
Value ($000) $17,310 Shares 1,775,415 Est. Cost $11.61 Unrealized +2.1%
CYMABAY THERAPEUTICS INC 7.0%
Value ($000) $16,766 Shares 1,124,459 Est. Cost $3.60 Unrealized
BIIB BIOGEN INC 7.0%
Value ($000) $16,622 Shares 64,676 Est. Cost $275.18 Unrealized -2.8%
AMLX AMYLYX PHARMACEUTICALS INC 6.8%
Value ($000) $16,225 Shares 886,143 Est. Cost $21.15 Unrealized 0.0%
CYTK CYTOKINETICS INC 6.1%
Value ($000) $14,588 Shares 495,168 Est. Cost $39.36 Unrealized -15.4%
SRPT SAREPTA THERAPEUTICS INC 6.0%
Value ($000) $14,353 Shares 118,401 Est. Cost $120.22 Unrealized -6.0%
HORIZON THERAPEUTICS PUB L 5.4%
Value ($000) $12,847 Shares 111,045 Est. Cost $92.95 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 4.9%
Value ($000) $11,732 Shares 807,969 Est. Cost $19.32 Unrealized -2.1%
ITEOS THERAPEUTICS INC 4.6%
Value ($000) $10,893 Shares 994,756 Est. Cost $14.98 Unrealized
ASND ASCENDIS PHARMA A/S 4.4%
Value ($000) $10,532 Shares 112,473 Est. Cost $108.42 Unrealized
ANAB ANAPTYSBIO INC 4.3%
Value ($000) $10,365 Shares 577,101 Est. Cost $19.08 Unrealized 0.0%
BMRN BIOMARIN PHARMACEUTICAL INC 4.1%
Value ($000) $9,705 Shares 109,685 Est. Cost $93.31 Unrealized -4.6%
ASTRIA THERAPEUTICS INC 3.8%
Value ($000) $9,094 Shares 1,219,093 Est. Cost $7.99 Unrealized
BCRX BIOCRYST PHARMACEUTICALS INC 2.9%
Value ($000) $6,956 Shares 982,458 Est. Cost $10.37 Unrealized -30.7%
ARGX ARGENX SE 2.1%
Value ($000) $4,953 Shares 10,074 Est. Cost $450.35 Unrealized
MORPHIC HLDG INC 1.3%
Value ($000) $3,133 Shares 136,743 Est. Cost $27.33 Unrealized
JASPER THERAPEUTICS INC 0.4%
Value ($000) $971 Shares 1,387,015 Est. Cost $0.70 Unrealized
MERUS N V 0.4%
Value ($000) $945 Shares 40,066 Est. Cost $23.58 Unrealized